Skip to Content

Journal of Clinical Medicine, Volume 4, Issue 4

2015 April - 14 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (14)

  • Review
  • Open Access
3 Citations
7,710 Views
14 Pages

Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease

  • Alexis Bosman,
  • Michael J. Edel,
  • Gillian Blue,
  • Rodney J. Dilley,
  • Richard P. Harvey and
  • David S. Winlaw

22 April 2015

Congenital heart disease places a significant burden on the individual, family and community despite significant advances in our understanding of aetiology and treatment. Early research in ischaemic heart disease has paved the way for stem cell techn...

(This article belongs to the Special Issue iPS Cells for Modelling and Treatment of Human Diseases)
  • Review
  • Open Access
41 Citations
15,229 Views
15 Pages

Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis?

  • Anna De Benedetto,
  • Takeshi Yoshida,
  • Sade Fridy,
  • Joo-Eun S. Park,
  • I.-Hsin Kuo and
  • Lisa A. Beck

21 April 2015

Atopic Dermatitis (AD), the most common chronic inflammatory skin disease, is characterized by an overactive immune response to a host of environmental allergens and dry, itchy skin. Over the past decade important discoveries have demonstrated that A...

(This article belongs to the Special Issue Epidemiology and Treatment of Atopic Eczema)
  • Review
  • Open Access
27 Citations
17,546 Views
12 Pages

21 April 2015

Hyponatremia is the most common, clinically-significant electrolyte abnormality seen in patients with aneurysmal subarachnoid hemorrhage. Controversy continues to exist regarding both the cause and treatment of hyponatremia in this patient population...

(This article belongs to the Special Issue Hyponatremia: Advances in Diagnosis and Management)
  • Review
  • Open Access
69 Citations
10,333 Views
26 Pages

20 April 2015

Diabetic kidney disease is the leading worldwide cause of end stage kidney disease and a growing public health challenge. The diabetic kidney is exposed to many environmental stressors and each cell type has developed intricate signaling systems desi...

(This article belongs to the Special Issue Diabetic Nephropathy)
  • Review
  • Open Access
9 Citations
9,874 Views
19 Pages

15 April 2015

Down syndrome (DS, trisomy 21), is the most common viable chromosomal disorder, with an incidence of 1 in 800 live births. Its phenotypic characteristics include intellectual impairment and several other developmental abnormalities, for the majority...

(This article belongs to the Special Issue iPS Cells for Modelling and Treatment of Human Diseases)
  • Review
  • Open Access
28 Citations
10,883 Views
31 Pages

Rational Combinations of Targeted Agents in AML

  • Prithviraj Bose and
  • Steven Grant

10 April 2015

Despite modest improvements in survival over the last several decades, the treatment of AML continues to present a formidable challenge. Most patients are elderly, and these individuals, as well as those with secondary, therapy-related, or relapsed/r...

(This article belongs to the Special Issue AML in the Molecular Age: From Biology to Clinical Management)
  • Review
  • Open Access
110 Citations
18,746 Views
31 Pages

Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

  • Nestor R. Ramos,
  • Clifton C. Mo,
  • Judith E. Karp and
  • Christopher S. Hourigan

10 April 2015

The limited sensitivity of the historical treatment response criteria for acute myeloid leukemia (AML) has resulted in a different paradigm for treatment compared with most other cancers presenting with widely disseminated disease. Initial cytotoxic...

(This article belongs to the Special Issue AML in the Molecular Age: From Biology to Clinical Management)
  • Review
  • Open Access
59 Citations
14,560 Views
21 Pages

Biological Treatments in Atopic Dermatitis

  • Andrea Montes-Torres,
  • Mar Llamas-Velasco,
  • Alejandra Pérez-Plaza,
  • Guillermo Solano-López and
  • Javier Sánchez-Pérez

3 April 2015

Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases that affect both children and adults with a prevalence of 30% and 10%, respectively. Even though most of patients respond satisfactory to topical anti-inflammatory dr...

(This article belongs to the Special Issue Epidemiology and Treatment of Atopic Eczema)
  • Review
  • Open Access
88 Citations
14,935 Views
20 Pages

Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus

  • Natalie Kash,
  • Michael A. Lee,
  • Ramya Kollipara,
  • Christopher Downing,
  • Jacqueline Guidry and
  • Stephen K. Tyring

3 April 2015

Since the discovery of the causal association between human papillomavirus (HPV) and cervical cancer, efforts to develop an effective prophylactic vaccine to prevent high-risk HPV infections have been at the forefront of modern medical research. HPV...

(This article belongs to the Special Issue Clinical Advances of Human Papillomaviruses)
  • Review
  • Open Access
58 Citations
8,633 Views
14 Pages

2 April 2015

Sub-Saharan Africa has the highest incidence of human papillomavirus (HPV) and cervical cancer in the world, which is further aggravated by the burden of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) disease with invasive...

(This article belongs to the Special Issue Clinical Advances of Human Papillomaviruses)
  • Review
  • Open Access
29 Citations
9,169 Views
12 Pages

31 March 2015

Inherited retinal diseases, such as age-related macular degeneration and retinitis pigmentosa, are the leading cause of blindness in the developed world. Currently, treatments for these conditions are limited. Recently, considerable attention has bee...

(This article belongs to the Special Issue iPS Cells for Modelling and Treatment of Human Diseases)
  • Review
  • Open Access
52 Citations
16,222 Views
19 Pages

Using iPS Cells toward the Understanding of Parkinson’s Disease

  • Roger Torrent,
  • Francesca De Angelis Rigotti,
  • Patrizia Dell'Era,
  • Maurizio Memo,
  • Angel Raya and
  • Antonella Consiglio

30 March 2015

Cellular reprogramming of somatic cells to human pluripotent stem cells (iPSC) represents an efficient tool for in vitro modeling of human brain diseases and provides an innovative opportunity in the identification of new therapeutic drugs. Patient-s...

(This article belongs to the Special Issue iPS Cells for Modelling and Treatment of Human Diseases)
  • Article
  • Open Access
11 Citations
7,414 Views
13 Pages

Sick Leave and Factors Influencing Sick Leave in Adult Patients with Atopic Dermatitis: A Cross-Sectional Study

  • Harmieke Van Os-Medendorp,
  • Simone Appelman-Noordermeer,
  • Carla Bruijnzeel-Koomen and
  • Marjolein De Bruin-Weller

27 March 2015

Background: Little is known about the prevalence of sick leave due to atopic dermatitis (AD). The current literature on factors influencing sick leave is mostly derived from other chronic inflammatory diseases. This study aimed to determine the preva...

(This article belongs to the Special Issue Epidemiology and Treatment of Atopic Eczema)
  • Review
  • Open Access
20 Citations
11,896 Views
31 Pages

25 March 2015

The current standard regimens for the treatment of acute myeloid leukemia (AML) are curative in less than half of patients; therefore, there is a great need for innovative new approaches to this problem. One approach is to target new treatments to th...

(This article belongs to the Special Issue AML in the Molecular Age: From Biology to Clinical Management)
XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383